Intracranial ependymomas: An analysis of prognostic factors and patterns of failure

Arnold dela Cruz Paulino, B. Chen Wen, John M. Buatti, David H. Hussey, Weining K. Zhen, Nina A. Mayr, Arnold H. Menezes

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

From 1965 to 1997, 49 patients were diagnosed and treated for intracranial ependymoma at one institution. Tumor location was infratentorial in two thirds, and pathology was low grade in 38 patients (78%). Gross total resection of the primary tumor was achieved in 21 (43%). Thirty-six patients received adjuvant radiotherapy; the entire neuraxis was treated in 14, whole brain in 10, and local field only in 12. Median follow-up was 9.6 years (range, 2-33 years). The 5-, 10-, and 15-year overall survival rates were 71.4%, 63.5%, and 63.5% for craniospinal radiotherapy, 60.0%, 60.0%, and 40.0% for whole brain radiotherapy, and 80.8%, 64.6%, and 64.6% for local field radiotherapy (p = 0.88). The 5-, 10-, and 15-year local control rates were 60.3%, 54.4%, and 48.9%. The prognostic factors for a better local control rate were gross total resection (p = 0.021) and low grade histology (p = 0.031). Seventeen of 43 (39.5%) MO patients did not respond to treatment; all had local failure and 4 also had a spinal relapse. Spinal relapse developed in 3 of 31 (10%) MO patients who did not receive spinal radiotherapy, whereas 1 of 12 (8%) who had spinal radiotherapy did not respond to treatment in the spine. The results of this study indicate that local radiotherapy is sufficient for MO patients with intracranial ependymoma.

Original languageEnglish (US)
Pages (from-to)117-122
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume25
Issue number2
DOIs
StatePublished - Apr 20 2002

Fingerprint

Ependymoma
Radiotherapy
Recurrence
Adjuvant Radiotherapy
Brain
Neoplasms
Histology
Spine
Survival Rate
Pathology
Therapeutics

Keywords

  • Gross total resection
  • Intracranial ependymoma
  • Local control
  • Radiotherapy volume

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Intracranial ependymomas : An analysis of prognostic factors and patterns of failure. / Paulino, Arnold dela Cruz; Wen, B. Chen; Buatti, John M.; Hussey, David H.; Zhen, Weining K.; Mayr, Nina A.; Menezes, Arnold H.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, No. 2, 20.04.2002, p. 117-122.

Research output: Contribution to journalArticle

Paulino, Arnold dela Cruz ; Wen, B. Chen ; Buatti, John M. ; Hussey, David H. ; Zhen, Weining K. ; Mayr, Nina A. ; Menezes, Arnold H. / Intracranial ependymomas : An analysis of prognostic factors and patterns of failure. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2002 ; Vol. 25, No. 2. pp. 117-122.
@article{c07f6952f26842bb989495fc620138dc,
title = "Intracranial ependymomas: An analysis of prognostic factors and patterns of failure",
abstract = "From 1965 to 1997, 49 patients were diagnosed and treated for intracranial ependymoma at one institution. Tumor location was infratentorial in two thirds, and pathology was low grade in 38 patients (78{\%}). Gross total resection of the primary tumor was achieved in 21 (43{\%}). Thirty-six patients received adjuvant radiotherapy; the entire neuraxis was treated in 14, whole brain in 10, and local field only in 12. Median follow-up was 9.6 years (range, 2-33 years). The 5-, 10-, and 15-year overall survival rates were 71.4{\%}, 63.5{\%}, and 63.5{\%} for craniospinal radiotherapy, 60.0{\%}, 60.0{\%}, and 40.0{\%} for whole brain radiotherapy, and 80.8{\%}, 64.6{\%}, and 64.6{\%} for local field radiotherapy (p = 0.88). The 5-, 10-, and 15-year local control rates were 60.3{\%}, 54.4{\%}, and 48.9{\%}. The prognostic factors for a better local control rate were gross total resection (p = 0.021) and low grade histology (p = 0.031). Seventeen of 43 (39.5{\%}) MO patients did not respond to treatment; all had local failure and 4 also had a spinal relapse. Spinal relapse developed in 3 of 31 (10{\%}) MO patients who did not receive spinal radiotherapy, whereas 1 of 12 (8{\%}) who had spinal radiotherapy did not respond to treatment in the spine. The results of this study indicate that local radiotherapy is sufficient for MO patients with intracranial ependymoma.",
keywords = "Gross total resection, Intracranial ependymoma, Local control, Radiotherapy volume",
author = "Paulino, {Arnold dela Cruz} and Wen, {B. Chen} and Buatti, {John M.} and Hussey, {David H.} and Zhen, {Weining K.} and Mayr, {Nina A.} and Menezes, {Arnold H.}",
year = "2002",
month = "4",
day = "20",
doi = "10.1097/00000421-200204000-00003",
language = "English (US)",
volume = "25",
pages = "117--122",
journal = "American Journal of Clinical Oncology: Cancer Clin",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Intracranial ependymomas

T2 - An analysis of prognostic factors and patterns of failure

AU - Paulino, Arnold dela Cruz

AU - Wen, B. Chen

AU - Buatti, John M.

AU - Hussey, David H.

AU - Zhen, Weining K.

AU - Mayr, Nina A.

AU - Menezes, Arnold H.

PY - 2002/4/20

Y1 - 2002/4/20

N2 - From 1965 to 1997, 49 patients were diagnosed and treated for intracranial ependymoma at one institution. Tumor location was infratentorial in two thirds, and pathology was low grade in 38 patients (78%). Gross total resection of the primary tumor was achieved in 21 (43%). Thirty-six patients received adjuvant radiotherapy; the entire neuraxis was treated in 14, whole brain in 10, and local field only in 12. Median follow-up was 9.6 years (range, 2-33 years). The 5-, 10-, and 15-year overall survival rates were 71.4%, 63.5%, and 63.5% for craniospinal radiotherapy, 60.0%, 60.0%, and 40.0% for whole brain radiotherapy, and 80.8%, 64.6%, and 64.6% for local field radiotherapy (p = 0.88). The 5-, 10-, and 15-year local control rates were 60.3%, 54.4%, and 48.9%. The prognostic factors for a better local control rate were gross total resection (p = 0.021) and low grade histology (p = 0.031). Seventeen of 43 (39.5%) MO patients did not respond to treatment; all had local failure and 4 also had a spinal relapse. Spinal relapse developed in 3 of 31 (10%) MO patients who did not receive spinal radiotherapy, whereas 1 of 12 (8%) who had spinal radiotherapy did not respond to treatment in the spine. The results of this study indicate that local radiotherapy is sufficient for MO patients with intracranial ependymoma.

AB - From 1965 to 1997, 49 patients were diagnosed and treated for intracranial ependymoma at one institution. Tumor location was infratentorial in two thirds, and pathology was low grade in 38 patients (78%). Gross total resection of the primary tumor was achieved in 21 (43%). Thirty-six patients received adjuvant radiotherapy; the entire neuraxis was treated in 14, whole brain in 10, and local field only in 12. Median follow-up was 9.6 years (range, 2-33 years). The 5-, 10-, and 15-year overall survival rates were 71.4%, 63.5%, and 63.5% for craniospinal radiotherapy, 60.0%, 60.0%, and 40.0% for whole brain radiotherapy, and 80.8%, 64.6%, and 64.6% for local field radiotherapy (p = 0.88). The 5-, 10-, and 15-year local control rates were 60.3%, 54.4%, and 48.9%. The prognostic factors for a better local control rate were gross total resection (p = 0.021) and low grade histology (p = 0.031). Seventeen of 43 (39.5%) MO patients did not respond to treatment; all had local failure and 4 also had a spinal relapse. Spinal relapse developed in 3 of 31 (10%) MO patients who did not receive spinal radiotherapy, whereas 1 of 12 (8%) who had spinal radiotherapy did not respond to treatment in the spine. The results of this study indicate that local radiotherapy is sufficient for MO patients with intracranial ependymoma.

KW - Gross total resection

KW - Intracranial ependymoma

KW - Local control

KW - Radiotherapy volume

UR - http://www.scopus.com/inward/record.url?scp=0036221560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036221560&partnerID=8YFLogxK

U2 - 10.1097/00000421-200204000-00003

DO - 10.1097/00000421-200204000-00003

M3 - Article

C2 - 11943886

AN - SCOPUS:0036221560

VL - 25

SP - 117

EP - 122

JO - American Journal of Clinical Oncology: Cancer Clin

JF - American Journal of Clinical Oncology: Cancer Clin

SN - 0277-3732

IS - 2

ER -